Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Timothy J. Scannell currently holds 16,999 shares of NovoCure Ltd (NVCR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Timothy J. Scannell has been a net seller of NVCR stock. They have purchased $94.7K and sold $20.6M worth of shares.
Timothy J. Scannell's most recent insider trade was on Jun 3, 2026, when they sold 16,999 shares at $0.00 per share.
Timothy J. Scannell serves as Executive at NovoCure Ltd (NVCR). They have executed 122 insider transactions totaling $20.7M over their tenure at the company.
Timothy J. Scannell holds the position of Executive at NovoCure Ltd, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 16 years and currently hold a stake valued at $0.
Timothy J. Scannell has shown a selling trading pattern, with $94.7K in total purchases and $20.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Timothy J. Scannell was on Nov 23, 2020, when they sold $9.4M worth of SYK shares. This transaction involved 40,356 shares at $232.86 per share.
Timothy J. Scannell currently owns 16,999 shares of NovoCure Ltd (NVCR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Timothy J. Scannell's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Timothy J. Scannell has 122 Form 4 filings on record as an insider at NovoCure Ltd.
Set alerts for Timothy J. Scannell and 40,000+ other insiders.